Integer (NYSE:ITGR) Cut to Hold at Wall Street Zen

Wall Street Zen cut shares of Integer (NYSE:ITGR) from a buy rating to a hold rating in a research report sent to investors on Sunday.

A number of other equities analysts have also weighed in on ITGR. Wells Fargo & Company reaffirmed an “equal weight” rating and issued a $80.00 price objective (down previously from $132.00) on shares of Integer in a research note on Friday, October 24th. Truist Financial increased their price target on shares of Integer from $86.00 to $95.00 and gave the company a “buy” rating in a report on Thursday, December 18th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Integer in a research note on Monday, December 29th. Citigroup upped their target price on Integer from $69.00 to $75.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Finally, KeyCorp lowered their target price on shares of Integer from $145.00 to $133.00 and set an “overweight” rating for the company in a research note on Tuesday, October 21st. Four investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $98.38.

Integer Stock Down 0.6%

ITGR stock opened at $85.77 on Friday. Integer has a twelve month low of $62.00 and a twelve month high of $146.36. The stock has a market cap of $3.01 billion, a P/E ratio of 35.89, a PEG ratio of 0.79 and a beta of 0.78. The business’s 50-day moving average price is $77.39 and its 200-day moving average price is $91.19. The company has a quick ratio of 2.45, a current ratio of 3.71 and a debt-to-equity ratio of 0.70.

Integer declared that its board has authorized a stock repurchase program on Tuesday, November 4th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the medical equipment provider to reacquire up to 8.3% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its shares are undervalued.

Insider Transactions at Integer

In other news, EVP Diron Smith purchased 1,116 shares of the company’s stock in a transaction that occurred on Friday, November 7th. The stock was purchased at an average cost of $67.19 per share, for a total transaction of $74,984.04. Following the completion of the transaction, the executive vice president owned 7,698 shares of the company’s stock, valued at $517,228.62. This trade represents a 16.96% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Cheryl C. Capps purchased 1,600 shares of the firm’s stock in a transaction dated Thursday, November 6th. The stock was acquired at an average cost of $66.70 per share, for a total transaction of $106,720.00. Following the completion of the purchase, the director owned 11,702 shares of the company’s stock, valued at approximately $780,523.40. This represents a 15.84% increase in their position. The SEC filing for this purchase provides additional information. Over the last three months, insiders bought 5,843 shares of company stock valued at $384,771. Insiders own 2.16% of the company’s stock.

Institutional Investors Weigh In On Integer

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ITGR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Integer by 4.0% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider’s stock valued at $2,539,000 after buying an additional 837 shares during the last quarter. Millennium Management LLC boosted its position in shares of Integer by 2,408.8% during the 1st quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock worth $14,531,000 after acquiring an additional 118,224 shares in the last quarter. Jones Financial Companies Lllp boosted its holdings in Integer by 79,888.9% in the first quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider’s stock valued at $850,000 after purchasing an additional 7,190 shares in the last quarter. United Services Automobile Association purchased a new position in shares of Integer in the 1st quarter valued at $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Integer by 4.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider’s stock worth $12,900,000 after purchasing an additional 4,873 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer News Roundup

Here are the key news stories impacting Integer this week:

• Negative Sentiment: Bleichmar Fonti & Auld LLP says a securities‑fraud class action has been filed against Integer and certain executives, notifying investors of the case and encouraging contact for lead‑plaintiff participation. ITGR INVESTORS: BFA Law Notifies Integer Holdings Corporation Investors with Losses of the Pending Securities Fraud Class Action and Upcoming February 9 Legal Deadline
• Negative Sentiment: Pomerantz LLP issued an investor alert reminding those who lost money in ITGR of the class action and upcoming deadlines to inquire about the litigation. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Integer Holdings Corporation of Class Action Lawsuit and Upcoming Deadlines – ITGR
• Negative Sentiment: Bernstein Liebhard LLP notified Integer shareholders of the class action and an upcoming deadline for affected investors (covers purchases July 25, 2024–Oct 22, 2025). INTEGER HOLDINGS CORPORATION (NYSE: ITGR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Integer Holdings Corporation Investors of Upcoming Deadline
• Negative Sentiment: Berger Montague PC advises investors of a securities‑fraud class action covering the same class period and highlights the Feb. 9 deadline to seek lead‑plaintiff status. Integer Holdings Corporation (ITGR) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
• Negative Sentiment: Rosen Law Firm reminded purchasers within the class period to secure counsel before the February 9 lead‑plaintiff deadline, emphasizing potential recovery through contingency arrangements. ITGR DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Integer Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ITGR
• Negative Sentiment: Bragar Eagel & Squire P.C. issued a reminder to contact the firm about the February 9 lead‑plaintiff deadline for alleged investor losses in Integer. INTEGER HOLDINGS CORPORATION CLASS ACTION: Bragar Eagel & Squire, P.C. Reminds Integer Holdings Corporation Investors to Contact the Firm Before the February 9th Class Action Lead Plaintiff Deadline
• Negative Sentiment: Bronstein, Gewirtz & Grossman LLC announced a class action alleging investor harm and urged affected shareholders to act; allegations reference misstatements about sales outlook. Bronstein, Gewirtz & Grossman LLC Urges Integer Holdings Corporation Investors to Act: Class Action Filed Alleging Investor Harm

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.